Dear awesome CureTogether friends,
We hope you are in good health, or finding good support along your health journey. We are writing with some wonderful news today!
CureTogether has been acquired by 23andMe, a personal genetic testing company that we greatly admire. Their focus on research into human disease is very aligned with our vision for enabling people to share their health information and collectively produce new knowledge.
This will be the first time ever that two extensive community-based research platforms, one primarily genetic and one phenotypic (symptom- and treatment-based) will be joined! We are very excited about the power of bringing our respective members together to make potentially major advances in solving many of the health conditions that affect so many of you, and us as well.
Please feel free to let us know your thoughts and questions about this, and rest assured that you will have freedom to decide how your data becomes part of this research. CureTogether will continue to be here to support you through your health journey.
To read more about the acquisition, see the coverage on TechCrunch or Health 2.0 News.
We look forward to continuing to serve you in this new joint project.
Hugs!
Alexandra and Daniel
CureTogether co-founders